The Relationship between the Therapy Cycle and the Success of Patent Ductus Arteriosus Closure Treatment in Premature Babies

Putri Amelia (1), William Chandra Wijaya (2), Robby Pandaibesi (3)
(1) a:1:{s:5:"en_US";s:119:"Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara Department of Pediatrics, Adam Malik Hospital";}, Indonesia,
(2) Department of Pediatrics, Adam Malik Hospital, Medan, Indonesia, Indonesia,
(3) Universitas Sumatera Utara, Sumatera Utara Indonesia, Indonesia

Abstract

Patent Ductus Arteriosus (PDA) is a disease often found in premature babies characterized by failure or delay in the closure of the Ductus Arteriosus (DA). PDA frequently occurs in babies born prematurely and is caused by high levels of prostaglandin E2 (PGE2) due to incomplete closure of the ductus and lung function. This condition can disrupt hemodynamics, so it needs to be closed. Closure can be done using cyclooxygenase (COX) inhibitor drugs, such as Indomethacin and Ibuprofen. Apart from that, paracetamol can also be used as an alternative to trigger the closure of the PDA. This study aims to establish the correlation between the medical intervention cycle and the efficacy of closing Patent Ductus Arteriosus (PDA) in preterm infants. The investigation employed an observational, retrospective, analytical approach along with a cross-sectional layout. The sampling technique in this research was total sampling. The sample obtained was 24 newborns, which was secondary data in the form of medical records obtained at the medical records installation of RSUP Haji Adam Malik Medan and Mother and Child Stella Maris Hospital Medan. All data were then processed and analyzed, and statistical tests were carried out using Spearman correlation tests with the SPSS application. The outcomes of this investigation, utilizing the Spearman correlation analysis, revealed a significant value of p = 0.001 (p<0.05) concerning the association between the duration of treatment and treatment efficacy and a significant value of p = <0.001 (p<0.05) concerning the treatment cycle and treatment efficacy. Thus, there was no relationship between the treatment cycle and the success of the treatment.

Full text article

Generated from XML file

References

Amelia P. Patent Ductus Arteriosus (PDA) 2019. Available from: http://repositori.usu.ac.id/handle/123456789/11568. Available from: http://repositori.usu.ac.id/handle/123456789/11568. Accessed: 26 Jan. 2023.

W. DA. Profil Penggunaan Parasetamol dan Ibuprofen pada Kasus Duktus Arteriosus Persisten. Airlangga University, 2017.

Amelia P, Adriansyah R, Lubis B, Akil M. The Outcomes of Transcatheter Closure in Patients with Patent Ductus Arteriosus at Haji Adam Malik General Hospital, Indonesia. Open Access Maced J Med Sci 2021;9(B):208–211. doi:10.3889/oamjms.2021.5764.

Aritonang IA, Lubis LD, Megawati ER. the Efficacy, Side-Effects, and Mortality Comparison Between Paracetamol and Ibuprofen in Patent Ductus Arteriosus Treatment for Premature Infants: a Systematic Review and Meta-Analysis. EuroMediterranean Biomed J 2021;16(29):124–130. doi:10.3269/1970-5492.2021.16.29.

Marcdante KJ, Kliegman RM, Jenson HB, Behrman RE. Nelson Ilmu Kesehatan Anak Esensial edisi 6. Singapore: Saunders Elsevier; 2014.

West N, Wales N, Heart I of MC. Guideline for the Management of Patent Ductus Arteriosus (PDA). North West Neonatal Oper Deliv Netw 2020:1–16. Available from: https://www.northwestchdnetwork.nhs.uk/wp-content/uploads/2021/05/GL-ODN-09-NW-Guideline-for-the-Management-of-PDA-Revised.pdf. Available from: https://www.northwestchdnetwork.nhs.uk/wp-content/uploads/2021/05/GL-ODN-09-NW-Guideline-for-the-Management-of-PDA-Revised.pdf. Accessed: 25 Dec. 2022.

Bardanzellu F, Neroni P, Dessì A, Fanos V. Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe? Biomed Res Int 2017;2017:1–25. doi:10.1155/2017/1438038.

Borges-Lujan M, Gonzalez-Luis GE, Roosen T, Huizing MJ, Villamor E. Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression. J Pers Med 2022;12(7):1143. doi:10.3390/jpm12071143.

Utomo MT, Etika R, Rahman MA, Sampoerna MTA, Samosir SM. Effect of Hemodynamic Significant Patent Ductus Arteriosus on Tissue Oxygenation in Preterm Infants using Near-Infrared Spectroscopy. Iran J Neonatol 2022;13(1):55–61. doi:10.22038/IJN.2022.55757.2040.

Terrin G, Di Chiara M, Boscarino G, Metrangolo V, Faccioli F, … De Curtis M. Morbidity associated with patent ductus arteriosus in preterm newborns: a retrospective case-control study. Ital J Pediatr 2021;47(1):9. doi:10.1186/s13052-021-00956-2.

Kuraesin I, Setia Sari R, Ratna Sari F. Pengaruh Nesting Terhadap Perubahan Fisiologi Dan Perilakubayi Prematur Di Ruang Perinatologi Rsud Kabupaten Tangerang Tahun 2020. J Heal Sains 2021;2(1):64–70. doi:10.46799/jhs.v2i1.95.

Sari O, Nova R, Bermawi H, Bahar E. Perbandingan Efektifitas dan Keamanan Parasetamol Intravena dan Ibuprofen Oral pada Penutupan Duktus Arteriosus Persisten pada Bayi Kurang Bulan. Sari Pediatr 2016;17(4):279. doi:10.14238/sp17.4.2015.279-84.

Chinawa JM, Chukwu BF, Chinawa AT, Duru CO. The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study. BMC Pulm Med 2021;21(1):79. doi:10.1186/s12890-021-01449-y.

Choi EK, Park KH, Choi BM. Size of Patent Ductus Arteriosus and Echocardiographic Markers of Shunt Volume in Preterm Infants Based on Postnatal Age. Front Pediatr 2021;9. doi:10.3389/fped.2021.635616.

Terrin G, Di Chiara M, Boscarino G, Versacci P, Di Donato V, … De Curtis M. Echocardiography-Guided Management of Preterms With Patent Ductus Arteriosus Influences the Outcome: A Cohort Study. Front Pediatr 2020;8. doi:10.3389/fped.2020.582735.

Su BH, Lin HY, Chiu HY, Tsai ML, Chen YT, Lu IC. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants. Pediatr Neonatol 2020;61(2):133–141. doi:10.1016/j.pedneo.2019.10.002.

Olgun H, Ceviz N, Kartal İ, Caner İ, Karacan M, … Becit N. Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety. Pediatr Neonatol 2017;58(1):29–35. doi:10.1016/j.pedneo.2015.04.017.

Ningsih R, Indrasari N. Faktor-Faktor Yang Berhubungan Dengan Kejadian Kelahiran Bayi Prematur 2012;V(2):95–100.

Hess DR, Faarc R. Retrospective Studies and Chart Reviews Introduction Case Series Case-Control Study Matched Case-Control Study Summary. Respir Care 2004;49(10):1171–1174.

Song JW, Chung KC. Observational Studies: Cohort and Case-Control Studies. Plast Reconstr Surg 2010;126(6):2234–2242. doi:10.1097/PRS.0b013e3181f44abc.

Authors

Putri Amelia
putri.amelia@usu.ac.id (Primary Contact)
William Chandra Wijaya
Robby Pandaibesi
Amelia, P., William Chandra Wijaya, & Pandaibesi, R. (2025). The Relationship between the Therapy Cycle and the Success of Patent Ductus Arteriosus Closure Treatment in Premature Babies. Qanun Medika - Medical Journal Faculty of Medicine Muhammadiyah Surabaya, 9(02). https://doi.org/10.30651/jqm.v9i02.25785

Article Details

Early Detection and Management of Critical Congenital Heart Disease

Mahrus Abdur Rahman, Sekar Putri Ramadhani, Prima Hari Nastiti, Taufiq Hidayat, Alit Utamayasa
Abstract View : 281
Download :173

Management of Habitual Patellar Dislocation in Pediatrics

Panji - Sananta, Ade Churie Tanjaya, Eka Noviya Fuzianingsih
Abstract View : 513
Download :264

Treatment in transient synovitis cases: A review

Panji - Sananta, Fernaldhi - Anggadha, Eka Noviya Fuzianingsih
Abstract View : 1077
Download :385

Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment

Ita Octafia, Dwi Octamy Sari, Novi Wulandari, Sandra Annisa, Linda Wahyuni Wongkar, Ferdias...
Abstract View : 1399
Download :600

The Role Of Denosumab

Raditya Pria Utama, Hesty Rohmatul Fajri
Abstract View : 1810
Download :535